XML 89 R72.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity - Valuation Assumptions of Granted Stock Options (Detail) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Equity [Abstract]      
Total weighted-average remaining vesting period in years 1 year 18 days 1 year 6 months 10 days 2 years 3 months
Stock-based compensation expense - Cost of Sales $ 141,000 $ 317,000 $ 321,000
Stock-based compensation expense - SG&A 71,000 108,000 836,000
Income tax benefit $ (54,000) $ (164,000) $ (444,000)